Should Microalbuminuria Ever Be Considered as a Renal Endpoint in Any Clinical Trial | Zendy

Ronney Shantouf | Zendy; Matthew J. Budoff | Zendy; Naser Ahmadi | Zendy; Arshia Ghaffari | Zendy; Ferdinand Flores | Zendy; Ajay K. Gopal | Zendy; Nazanin Noori | Zendy; Jennie Jing | Zendy; Csaba P. Kövesdy | Zendy; Kamyar KalantarZadeh | Zendy; Matthew R. Weir | Zendy; Zohra Tumur | Zendy; Hidehisa Shimizu | Zendy; Atsushi Enomoto | Zendy; Hitoshi Miyazaki | Zendy; Toshimitsu Niwa | Zendy; Dick de Zeeuw | Zendy; Richard J. Glassock | Zendy; Joyce R. Byers | Zendy; Gregory B. Russell | Zendy; Robert J. Stratta | Zendy; Anthony J. Bleyer | Zendy; Yonghong Shi | Zendy; Chunyang Du | Zendy; Yanling Zhang | Zendy; Yunzhuo Ren | Zendy; Jun Hao | Zendy; Song Zhao | Zendy; Yao Fang | Zendy; Huijun Duan | Zendy; Meyeon Park | Zendy; Steven G. Coca | Zendy; Sagar U. Nigwekar | Zendy; Amit X. Garg | Zendy; Susan Garwood | Zendy; Chirag R. Parikh | Zendy; Marshall Joffe | Zendy; Chiyuan Hsu | Zendy; Harold I. Feldman | Zendy; J. Richard Landis | Zendy; L. Lee Hamm | Zendy; Utpal Sen | Zendy; Charu Munjal | Zendy; Natia Qipshidze | Zendy; Oluwasegun A Abe | Zendy; Riyad Gargoum | Zendy; Suresh C. Tyagi | Zendy; Barry I. Freedman | Zendy; Zak K. Shihabi | Zendy; Lilian Andries | Zendy; Cesar Y. Cardona | Zendy; Todd P. Peacock | Zendy; Hiddo J.L. Heerspink | Zendy; George L. Bakris | Zendy; Claire E. Hills | Zendy; Nigel J. Brunskill | Zendy; Paul E. Squires | Zendy; Seyed M. HosseiniMoghaddam | Zendy; Afagh Zarei | Zendy; Seyed Moayed Alavian | Zendy; Mehdi Mansouri | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Should Microalbuminuria Ever Be Considered as a Renal Endpoint in Any Clinical Trial

Author(s) -

Ronney Shantouf,

Matthew J. Budoff,

Naser Ahmadi,

Arshia Ghaffari,

Ferdinand Flores,

Ajay K. Gopal,

Nazanin Noori,

Jennie Jing,

Csaba P. Kövesdy,

Kamyar KalantarZadeh,

Matthew R. Weir,

Zohra Tumur,

Hidehisa Shimizu,

Atsushi Enomoto,

Hitoshi Miyazaki,

Toshimitsu Niwa,

Dick de Zeeuw,

Richard J. Glassock,

Joyce R. Byers,

Gregory B. Russell,

Robert J. Stratta,

Anthony J. Bleyer,

Yonghong Shi,

Chunyang Du,

Yanling Zhang,

Yunzhuo Ren,

Jun Hao,

Song Zhao,

Yao Fang,

Huijun Duan,

Meyeon Park,

Steven G. Coca,

Sagar U. Nigwekar,

Amit X. Garg,

Susan Garwood,

Chirag R. Parikh,

Marshall Joffe,

Chiyuan Hsu,

Harold I. Feldman,

J. Richard Landis,

L. Lee Hamm,

Utpal Sen,

Charu Munjal,

Natia Qipshidze,

Oluwasegun A Abe,

Riyad Gargoum,

Suresh C. Tyagi,

Barry I. Freedman,

Zak K. Shihabi,

Lilian Andries,

Cesar Y. Cardona,

Todd P. Peacock,

Hiddo J.L. Heerspink,

George L. Bakris,

Claire E. Hills,

Nigel J. Brunskill,

Paul E. Squires,

Seyed M. HosseiniMoghaddam,

Afagh Zarei,

Seyed Moayed Alavian,

Mehdi Mansouri

Publication year - 2010

Publication title -

american journal of nephrology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.394

H-Index - 85

eISSN - 1421-9670

pISSN - 0250-8095

DOI - 10.1159/000313548

Subject(s) - medicine , microalbuminuria , clinical endpoint , clinical trial , endpoint determination , intensive care medicine , proteinuria , renal function , kidney

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom

About

About Careers Publisher Partners Contact Us Get Organisational Trial or Quote

Learn

FAQs Blog Terms of Use Privacy Policy

Download the Zendy App

Address

About

Learn

Download the Zendy App

Discover

Explore